Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine
Recruiting · NCT06573320 · Interventional (participants receive a specific treatment) · Lead sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital
View the official record on ClinicalTrials.gov →Interventions studied
physical exercise
What this trial is about
This prospective study aims to investigate the effects of exercise on clinical symptoms, cognitive performance, and quality of life in schizophrenia patients treated with Clozapine.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients treated who were diagnosed with schizophrenia according to DSM-V criteria by psychiatrist at the Turkish Ministry of Health Kartal Dr. Lütfi Kırdar City Hospital
- using a therapeutic dose of 300-500 mg/day of clozapine,
Exclusion criteria
- pregnancy
Where it is running
1 location listed.
- Kartal Dr Lütfi Kırdar Şehir Hastanesi - Istanbul, Turkey (Türkiye)